For patients with "good-risk" ductal carcinoma in situ (DCIS) who underwent breast-conserving surgery and did not receive ...

The trial explores how Apple smartwatches can help tailor daily blood thinner use for patients with atrial fibrillation.

OSF Cancer Institute is one of the chosen few participants in an exciting new cancer treatment trial program. The founder of ...

Discover key challenges in clinical trial design and learn how the right software can significantly boost the likelihood of ...

Creating contingency plans against geopolitical uncertainty was a key theme at the 2024 Outsourcing in Clinical Trials and ...

On November 8, the Department of Labor (DOL) issued an opinion letter addressing an interesting question under the Family and ...

RevBio Receives Both FDA Approval to Expand its Clinical Trial and CMS Reimbursement for its Regenerative Bone Adhesive for ...

BNT23001, a sublingual formulation of cladribine, will be tested in a pilot clinical trial in 2025 comparing it to MS ...

A new Houston-developed AI model is being used in a clinical trial for the first time, and researchers are watching for more.

The trial (NCT06207370) evaluates tafenoquine combined with standard treatment for babesiosis, addressing a critical unmet ...

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States, whose ...

After a lucrative IPO in September, Richmond-based BioAge is seeing its biotech fortunes shift with its stock falling over 70 ...